ArticleAnnals of surgery2013

Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancer.

Mark Shapiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.